Clinigen Group (CLIN)

 

Latest News

Form 8.3 - Clinigen Group plc

Form 8.3 - Clinigen Group plc Putnam Investments FORM 8.3 PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the ?Code?) 1. KEY INFORMATION (a) Full name of discloser: ? Putnam Investments, LLC (b) Owner or controller of interests and shor...

Form 8.3 - Clinigen Group plc

RNS Number: 6080R BlackRock Group 22 September 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: BlackRock, Inc. (b) Owner...

Form 8.3 - Clinigen Group PLC

Form 8.3 - Clinigen Group PLC Sand Grove Capital Management LLP FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the ?Code?) 1. KEY INFORMATION (a) Full name of discloser: ? Sand Grove C...

Form 8.3 - [Clinigen Group plc]

RNS Number: 6027R Schroders PLC 22 September 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Schroders plc (b) Owner or c...

All News

DateHeadlineSource
22-09-17Form 8.3 - Clinigen Group plcRNS
22-09-17Form 8.3 - Clinigen Group plcRNS
22-09-17Form 8.3 - Clinigen Group PLCRNS
22-09-17Form 8.3 - [Clinigen Group plc]RNS
22-09-17Form 8.3 - Clinigen Group plcRNS
22-09-17Form 8.3 - Clinigen Group plcRNS
22-09-17Form 8.3 - Clinigen Group plcRNS
22-09-17Form 8.3 - Clinigen Group plcRNS
22-09-17Form 8.3 - Clinigen Group plcRNS
22-09-17Form 8.3 - Clinigen Group PLCRNS
22-09-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
22-09-17Form 8.3 - Clinigen Group PlcRNS
21-09-17Form 8.3 - Clinigen Group plcRNS
21-09-17Form 8.3 - Clinigen Group PlcRNS
21-09-17Form 8.3 - [Clinigen Group plc]RNS
21-09-17Form 8.3 - Clinigen Group PlcRNS
21-09-17Form 8.3 - Clinigen Group PlcRNS
21-09-17Form 8.3 - Quantum Pharma plcRNS
21-09-17Form 8.3 - Clinigen Group PLCRNS
21-09-17Form 8.3 - Clinigen Group PLCRNS
21-09-17Form 8.3 - Clinigen group PLCRNS
21-09-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
20-09-17Form 8.3 - Clinigen Group plcRNS
20-09-17Form 8.3 - [Clinigen Group plc]RNS
20-09-17Form 8.3 - Quantum Pharma plcRNS
20-09-17Form 8.3 - Clinigen Group PlcRNS
20-09-17Rule 2.9 AnnouncementRNS
20-09-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
19-09-17Form 8.3 - Clinigen Group plcRNS
19-09-17Form 8.3 - Clinigen Group PLCRNS
19-09-17Form 8.3 - Clinigen Group PLCRNS
19-09-17Form 8.3 - Clinigen Group plcRNS
19-09-17Issue of EquityRNS
19-09-17Form 8.3 - [Clinigen Group plc]RNS
19-09-17Form 8.3 - Quantum Pharma plcRNS
19-09-17Form 8.5 (EPT/RI) - Clinigen Group PlcRNS
18-09-17Form 8.3 - Clinigen Group plcRNS
18-09-17Form 8.3 - Clinigen Group PlcRNS
18-09-17Form 8.3 - Clinigen Group plcRNS
18-09-17Form 8.3 - Quantum Pharma plcRNS

RSS feeds

  • Editorial news feed for LSE:CLIN Editorial
  • Regulatory news feed for LSE:CLIN Regulatory